Medicine
Volume 38, Issue 2 , Pages 97-100, February 2010

Large vessel vasculitides

Caroline M Cardy BMBCh BSc MRCP DPhil is a rheumatology Specialist Registrar at City Hospital, Birmingham, UK. Competing interests: none declared

David Carruthers MBBS FRCP PhD is Consultant Rheumatologist at City Hospital, Birmingham, UK. Competing interests: none declared

Abstract 

The two major primary large vessel vasculitides are giant cell arteritis (GCA) and Takayasu's arteritis (TA). Both are idiopathic systemic inflammatory conditions characterized by granulomatous inflammation of large and medium-sized arteries. Although they share similar histological features, the demographics and clinical presentation of the two diseases are quite different. TA affects a younger age set, predominantly affects the aorta and its main branches and tends to be a two-phase disease with inflammatory and occlusive stages. GCA increases in prevalence with age and classically affects the temporal and other cranial arteries, although the aorta and its primary branches can be affected. Constitutional symptoms are a feature of both diseases. Vascular symptoms are dependent on the pattern of arterial involvement. Headache, jaw claudication and visual disturbance are typical symptoms of GCA. Limb claudication and diminished limb pulses are characteristic of TA. Temporal artery biopsy and angiography remain the gold standard for diagnosis of GCA and TA, respectively. New imaging modalities are challenging this practice; they also have the potential to allow monitoring of disease activity. Treatment has seen major advances in the last decade. With the advent of vigorous immunosuppressive therapy and new means for intervention with percutaneous transluminal angioplasty supported by stenting, it is hoped that the prognosis of patients with large vessel vasculitis will improve.

Keywords: angiography, giant cell arteritis, immunosuppression, large vessel vasculitis, Takayasu arteritis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1357-3039(09)00321-1

doi:10.1016/j.mpmed.2009.10.013

Medicine
Volume 38, Issue 2 , Pages 97-100, February 2010